Reviews on Recent Clinical Trials
Title:Meet Our Editorial Board Member
Volume: 12 Issue: 2
Author(s): Thomas P. Monath*
Affiliation:
- Acambis Inc. Cambridge, MA,United States
Export Options
About this article
Cite this article as:
Monath P. Thomas*, Meet Our Editorial Board Member, Reviews on Recent Clinical Trials 2017; 12 (2) . https://dx.doi.org/10.2174/157488711202170510202430
DOI https://dx.doi.org/10.2174/157488711202170510202430 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
15
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era
Current HIV Research COVID-19 Invades Several Important Organs other than the Lungs: Organs Crosstalk
Coronaviruses Cannabinoids and Memory; Animal Studies
Current Drug Targets - CNS & Neurological Disorders Treatment of Severe Cases of Pandemic (H1N1) 2009 Influenza: Review of Antivirals and Adjuvant Therapy
Recent Patents on Anti-Infective Drug Discovery Recent Advances in Antiviral Nucleoside and Nucleotide Therapeutics
Current Topics in Medicinal Chemistry EPO Relies upon Novel Signaling of Wnt1 that Requires Akt1, FoxO3a,GSK-3β, and β-Catenin to Foster Vascular Integrity during Experimental Diabetes
Current Neurovascular Research Altering the Tropism of Lentiviral Vectors through Pseudotyping
Current Gene Therapy Neuroprotective Actions of Flavones and Flavonols: Mechanisms and Relationship to Flavonoid Structural Features
Central Nervous System Agents in Medicinal Chemistry Nose-to-Brain Drug Delivery by Nanoparticles in the Treatment of Neurological Disorders
Current Medicinal Chemistry 14-3-3 Protein in CSF Reflects SIV-Mediated Pre-Synaptic Damage
Current HIV Research NS3 Helicases as Drug Targets
Current Chemical Biology Recent Advances in the Development of Anti-Infective Prophylactic and/or Therapeutic Agents Based on Toll-Like Receptor (TLRs)
Recent Patents on Anti-Infective Drug Discovery Heterocycles in the Treatment of Neglected Tropical Diseases
Current Medicinal Chemistry Novel Opportunities to Study and Block Interactions between Viruses and Cell Surface Heparan Sulfates by using Dispirotripiperazines
Letters in Drug Design & Discovery Nucleic Acid-Based Therapeutics for Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry HIV-1 Proteins, Tat and gp120, Target the Developing Dopamine System
Current HIV Research Superheated Water as Solvent in Microwave Assisted Organic Synthesis of Compounds of Valuable Pharmaceutical Interest
Current Organic Chemistry Editorial (Thematic Issue: The Monocyte/Macrophage in the Pathogenesis of AIDS: The Next Frontier for Therapeutic Intervention in the CNS and Beyond: Part II)
Current HIV Research Chemotherapy In Japanese Encephalitis: Are We There Yet?
Infectious Disorders - Drug Targets Understanding Helicases as a Means of Virus Control
Current Pharmaceutical Design